IL53164A - Synthesis of methotrexate - Google Patents

Synthesis of methotrexate

Info

Publication number
IL53164A
IL53164A IL53164A IL5316477A IL53164A IL 53164 A IL53164 A IL 53164A IL 53164 A IL53164 A IL 53164A IL 5316477 A IL5316477 A IL 5316477A IL 53164 A IL53164 A IL 53164A
Authority
IL
Israel
Prior art keywords
methotrexate
synthesis
Prior art date
Application number
IL53164A
Other languages
English (en)
Other versions
IL53164A0 (en
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of IL53164A0 publication Critical patent/IL53164A0/xx
Publication of IL53164A publication Critical patent/IL53164A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/535—Organo-phosphoranes
    • C07F9/5355—Phosphoranes containing the structure P=N-
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL53164A 1976-11-17 1977-10-19 Synthesis of methotrexate IL53164A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/742,450 US4080325A (en) 1976-11-17 1976-11-17 Synthesis of methotrexate

Publications (2)

Publication Number Publication Date
IL53164A0 IL53164A0 (en) 1977-12-30
IL53164A true IL53164A (en) 1980-06-30

Family

ID=24984894

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53164A IL53164A (en) 1976-11-17 1977-10-19 Synthesis of methotrexate

Country Status (11)

Country Link
US (1) US4080325A (ro)
JP (1) JPS5398996A (ro)
AU (1) AU511019B2 (ro)
CA (1) CA1077477A (ro)
DE (1) DE2741270A1 (ro)
FR (1) FR2371446A1 (ro)
GB (3) GB1595337A (ro)
IL (1) IL53164A (ro)
NL (1) NL7712154A (ro)
RO (1) RO75303A (ro)
SU (1) SU738511A3 (ro)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306064A (en) * 1980-03-25 1981-12-15 Ellard James A Synthesis of 2,4-diamino-6-hydroxymethylpteridine
US4421913A (en) * 1980-04-23 1983-12-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Separation of triphenylphosphine oxide from methotrexate ester and purification of said ester
DE4309123C2 (de) * 1993-03-22 1998-07-02 Mack Chem Pharm Verfahren zur Herstellung von 2,4-Diamino-6-(hydroxymethyl)pteridin-Salzen
US5382582A (en) * 1993-03-26 1995-01-17 Chan; Carcy L. Methotrexate analogs and methods of using same
DE19503966C2 (de) * 1995-02-07 1998-07-02 Mack Chem Pharm Kristallmodifikation von 2,4-Diamino-6-hydroxymethylpteridin-Hydrobromid, Verfahren zu dessen Herstellung und dessen Verwendung
US5698556A (en) * 1995-06-07 1997-12-16 Chan; Carcy L. Methotrexate analogs and methods of using same
GB9617727D0 (en) 1996-08-23 1996-10-02 Knoll Ag Process
WO1998024477A1 (en) 1996-12-06 1998-06-11 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
GB9626746D0 (en) * 1996-12-23 1997-02-12 Knoll Ag Process
DE19904812A1 (de) * 1999-02-05 2000-08-10 Basf Ag Verfahren zur Herstellung von Folsäure
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
MXPA05007019A (es) * 2002-12-30 2005-08-18 Amgen Inc Terapia de combinacion con factores co-estimuladores.
US6921667B2 (en) 2003-03-07 2005-07-26 Prometheus Laboratories, Inc. Methods for direct detection of individual methotrexate metabolites
US7582282B2 (en) 2003-08-29 2009-09-01 Prometheus Laboratories Inc. Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
WO2006031614A2 (en) * 2004-09-10 2006-03-23 Tosk, Inc. Reduced toxicity methotrexate formulations and methods for using the same
US20060286571A1 (en) 2005-04-28 2006-12-21 Prometheus Laboratories, Inc. Methods of predicting methotrexate efficacy and toxicity
CN101355952B (zh) 2005-11-28 2012-03-21 韦罗制药有限公司 用于减少肾毒性的组合物及其使用方法
CN102014919B (zh) 2008-03-03 2015-02-25 托斯克公司 减少毒性的甲氨蝶呤佐剂及其使用方法
JP5732039B2 (ja) 2009-03-20 2015-06-10 アンタレス・ファーマ・インコーポレーテッド 危険有害性薬剤の注入システム
US9261509B2 (en) 2010-09-13 2016-02-16 Thierry Dervieux Methods for monitoring methotrexate therapy
ES2553834T3 (es) * 2010-12-03 2015-12-14 Kocak Farma Ilac Ve Kimya San. A.S Un nuevo método para producir agentes antifolatos que tienen ácido glutámico como parte de su estructura
UA117556C2 (uk) 2011-05-16 2018-08-27 Джензайм Корпорейшн Спосіб збільшення ефективності терапевтичного засобу шляхом введення метотрексату
ES2656292T3 (es) 2012-05-01 2018-02-26 Translatum Medicus Inc. Métodos de tratamiento y diagnóstico de enfermedades oculares que causan ceguera
CN102952137A (zh) * 2012-10-08 2013-03-06 天津科创医药中间体技术生产力促进有限公司 一种2,4-二氨基-6-溴甲基蝶啶的制备方法
EP4349414B1 (en) 2014-12-23 2025-10-15 Dyve Biosciences, Inc. Formulations for transdermal administration
CN107698592A (zh) * 2016-08-09 2018-02-16 浙江海正药业股份有限公司 一种甲氨蝶呤盐的纯化工艺
US20190083527A1 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Method of administration and treatment
CN113461689B (zh) * 2021-06-30 2023-03-31 浙江浙北药业有限公司 一种甲氨蝶呤化合物的制备方法
CN116768749B (zh) * 2023-06-21 2025-06-03 重庆药友制药有限责任公司 一种甲氨蝶呤中间体的精制方法
CN120157673B (zh) * 2025-03-21 2025-11-14 江西贝美药业有限公司 一种甲氨蝶呤纯化新方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989703A (en) * 1974-03-22 1976-11-02 Institutul Oncologic Process of preparing N[p-{[(2,4-diamino-6-pteridyl)-methyl]N10 -methylamino}-benzoyl]-glutamic acid
FR2270245A1 (en) * 1974-03-26 1975-12-05 Inst Oncologic Biologically active cpd used in cancer therapy - i.e. N-p-(2,4-diamino-6-pteridyl-methyl-nitrogen-10-methylamino-benzoy- l)-glutamic acid

Also Published As

Publication number Publication date
CA1077477A (en) 1980-05-13
AU3039377A (en) 1979-05-17
FR2371446A1 (fr) 1978-06-16
DE2741270A1 (de) 1978-05-18
US4080325A (en) 1978-03-21
GB1595337A (en) 1981-08-12
IL53164A0 (en) 1977-12-30
SU738511A3 (ru) 1980-05-30
AU511019B2 (en) 1980-07-24
NL7712154A (nl) 1978-05-19
JPS5398996A (en) 1978-08-29
GB1595102A (en) 1981-08-05
GB1595338A (en) 1981-08-12
RO75303A (ro) 1980-11-30

Similar Documents

Publication Publication Date Title
IL53164A0 (en) Synthesis of methotrexate
JPS52100574A (en) Manufacture of preepreg
ZA771900B (en) Manufacture of hydrocarbons
JPS52107067A (en) Manufacture of preepreg
JPS5569598A (en) Manufacture of 4*66dii00*aminoglycosyl**1*33 diaminocyclitols
JPS5756449A (en) Manufacture of aminourea
JPS5436270A (en) Production of intermediate for gammaapyrone synthesis
IL51285A0 (en) Determination of methotrexate
JPS5294899A (en) Synthesis of boujacite
JPS5288094A (en) Determination of antithrombimm3
JPS5555161A (en) Intermediate for manufacture of 1*55disubstitutedd22pyrrolidones
ZA773466B (en) Chemical synthesis
JPS5350086A (en) Synthesis of diamond
JPS52108388A (en) Manufacture of solid adsorbents
JPS53130491A (en) Synthesis of nnacyll llthreonine
JPS52122360A (en) Prepatation of 33chlorophthalide
IL49662A0 (en) Determination of transcobalamins
IL52894A0 (en) Synthesis of beta-aminostyrenes
JPS52102210A (en) Synthesis of dd22 aminoo11butanol
IL49483A0 (en) Synthesis of 1,2,3,4-tetrahydro-4-oxo-(or-oxy-)-1-naphthylureas
JPS5319939A (en) Structure of photoomasks
JPS52148070A (en) Novel synthesis of 55acyll33aryloxazolidinee 2*44diones
JPS5350087A (en) Synthesis of diamond
JPS539754A (en) Ppoduction of bzz11 bromobenzoanthrone
JPS5328117A (en) Freezeedryymethod of panthethine